Specialty Grand Challenge for Brain Disease Mechanisms

[...]there is a major unmet need to identify treatment options, which are disease modifying and thereby affect fundamental mechanisms implicated in pathogenic processes leading to disease and its progression. Specifically, core metabolites, such as adenosine are uniquely linked to energy homeostasis...

Full description

Saved in:

Bibliographic Details
Published in:	Frontiers in molecular neuroscience Vol. 14; p. 689903
Main Author:	Boison, Detlev
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Research Foundation 10-05-2021 Frontiers Media S.A
Subjects:	Adenosine receptors Coronaviruses COVID-19 disease burden disease mechanism disease modification DNA methylation Energy balance Epigenetics Gene expression global approaches Histones Homeostasis Metabolites Molecular Neuroscience Nervous system network pharmacology Neuromodulation Parkinson's disease Stem cells Traumatic brain injury global approaches disease mechanism network pharmacology neurological disorders CNS disorders disease burden epigenetics disease modification
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[...]there is a major unmet need to identify treatment options, which are disease modifying and thereby affect fundamental mechanisms implicated in pathogenic processes leading to disease and its progression. Specifically, core metabolites, such as adenosine are uniquely linked to energy homeostasis (ATP), used as building blocks of biomolecules (RNA, including poly-A tails of mRNAs), coupled to transmethylation reactions (DNA and histone methylation), and act as receptor ligands (adenosine receptors) (Boison, 2013; Boison and Yegutkin, 2019). [...]adenosine is a unique network regulator linking metabolism and gene expression with neuromodulation. [...]adenosine augmentation therapies, e.g., through engineered stem cells (Fedele et al., 2004; Li et al., 2009), are uniquely suited to restore network homeostasis, and to not only suppress comorbid symptoms but also to exert lasting disease modifying therapeutic effects (Li et al., 2008; Boison, 2012; Shen et al., 2012; Williams-Karnesky et al., 2013). Because epigenetic mechanisms regulate gene expression, there is an urgent need to invest in the field of epigenomics which is one of the remaining frontiers in neuroscience.
Bibliography:	SourceType-Other Sources-1 content type line 63 ObjectType-Editorial-2 ObjectType-Commentary-1 Edited and reviewed by: Jochen C. Meier, Technische Universitat Braunschweig, Germany This article was submitted to Brain Disease Mechanisms, a section of the journal Frontiers in Molecular Neuroscience
ISSN:	1662-5099 1662-5099
DOI:	10.3389/fnmol.2021.689903